Paradeep Phosphates Q1 FY27 Profit at ₹392 Cr; Revenue ₹6,124 Cr
Paradeep Phosphates Limited reported unaudited standalone and consolidated results for Q1 FY27. Total income stood at ₹6,145.82 crore, with revenue from operations at ₹6,124.25 crore. Profit for the period was ₹392.60 crore (standalone) and ₹392.54 crore (consolidated). EPS was ₹3.78 for both.
The results show a healthy financial performance for the quarter, which is material for investors.
The company reported positive financial results with significant revenue and profit for the quarter.
Paradeep Phosphates Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's Board of Directors, in a meeting held on July 28, 2026, approved these results, which were recommended by the Audit Committee.
The standalone financial results for the quarter show a total income of ₹6,145.82 crore, with revenue from operations at ₹6,124.25 crore. Total expenses were ₹5,641.40 crore, leading to a profit before tax of ₹526.22 crore and a profit for the period of ₹392.60 crore. Earnings per share (EPS) stood at ₹3.78.
Consolidated financial results also reported a total income of ₹6,145.82 crore and revenue from operations at ₹6,124.25 crore. Total expenses amounted to ₹5,641.40 crore. The profit before tax was ₹526.16 crore, and the profit for the period was ₹392.54 crore. Consolidated basic and diluted EPS were both ₹3.78.
The financial statements reflect the impact of the Composite Scheme of Arrangement for the amalgamation of Mangalore Chemicals & Fertilizers Limited (MCFL) with Paradeep Phosphates Limited, with an appointed date of April 1, 2024. This scheme has been approved by the National Company Law Tribunal (NCLT).
The auditors, B S R & Co. LLP, have provided a limited review report on these unaudited results, stating that nothing has come to their attention to indicate material misstatements.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.